Post by
biorun on Nov 23, 2022 5:04pm
Looks like up from here
Good news recently but great news today. Some may not like Wanbang but in the end the two ends of this legacy arrangement picked themselves up, have a war chest of scientific data, know how to produce the pills, and now focussed on something more relevant towards moving another (or two) deal forward.
If that deal happens, that will be 3 major biopharmas working with Sirona. The 4th? - that is the human indication they refer to, and maybe next year a 5th and 6th on anti-aging and anti-viral.
Its all up from here in my personal opinion. 11.5 cents in hindsight now looks like the steal of the century, and maybe also big baby's buy at 16 cents will turn green as well.
GLTA.
Comment by
lscfa on Nov 23, 2022 6:00pm
If co. wants to instil investor confidence then be transparent. Why the hell did Wanbang pass on commercializing 039 in China? China specific patent problem? Why does Wanbang think others will want to commercialize 039 for rest of world?
Comment by
MirrorWorldMan on Nov 23, 2022 7:37pm
China allowed early SGLT2 generics.